# Unaudited supplementary information for the financial year ended 31 July 2022 (continued)
## Appendix 2: Remuneration Policy
The Company has adopted a remuneration policy (the "Remuneration Policy") in accordance with the remuneration requirements of the UCITS Regulations. These provisions require Management Companies and self-managed UCITS to establish and apply remuneration policies and practices that promote sound and effective risk management, and do not encourage risk taking which is inconsistent with the risk profile of the UCITS. The Remuneration Policy sets out practices for those receiving total remuneration whose professional activities have a material impact on the risk profile of the Company, that are consistent with and promote sound and effective risk management and do not encourage risk-taking which is inconsistent with the risk profiles, rules or constitutional document of the Company.
The Company shall apply the provisions of its remuneration policy to its ‘Identified Staff’ being “those categories of staff, including senior management, risk takers and control functions receiving total remuneration that falls within the remuneration bracket of senior management and risk takers whose professional activities have a material impact on the risk profiles of the management companies or of the UCITS that they manage”.

## The Company has determined that the following staff members would fall within the definition of “Identified Staff”:

## - Members of the Board of Directors
The Company must comply with the UCITS Directive remuneration principles in a way and to the extent that is appropriate to its size, its internal organisation and the nature scope and complexity of its activities. The Directors who are not employees of the investment manager of the Company receive a fixed annual fee for their services as disclosed in the prospectus of the Company and do not receive performance-based remuneration therefore avoiding a potential conflict of interest.

## The Company does not pay any variable remuneration to any of its Identified Staff. Accordingly, the principles in respect of

## variable remuneration as outlined in the UCITS Directive are not applicable.
In accordance with paragraph 16 of the Guidelines on Sound Remuneration Policies under the UCITS Directive ESMA 2016/575 (the “ESMA Guidelines”), the Company will ensure that (a) the Identified Staff of any investment manager appointed by it to discharge investment management functions (including risk management) are subject to regulatory requirements on remuneration which are equally as effective as those applicable under the ESMA Guidelines or (b) contractual arrangements are in place between the Company and the relevant investment manager in order to ensure that there is no circumvention of the remuneration rules set down in the ESMA Guidelines. The Company has received appropriate confirmation that its delegate, the Investment Manager, is subject to regulatory requirements on remuneration which are equally as effective as those applicable under the ESMA Guidelines.

## The Company does not pay any fixed or variable remuneration to identified staff of the Investment Managers.

Translation (ENFR, 2022-07-31):
# Informations complémentaires non auditées pour l’exercice clos le 31 juillet 2022 (suite)
## Annexe 1 : Transparence des opérations de financement sur titres et de la réutilisation (suite)

## Données de transaction agrégées

## Type et devise de la garantie

## Il y a une garantie détenue sur les Contrats d’échange sur rendement total.

## Type de garantie : Obligations d’État (néant), Liquidités (néant) USD (en milliers)

## Date d’échéance

## Les dates d’échéance des contrats d’échange sur rendement total par contrepartie sont indiquées dans l’état des investissements de chaque Compartiment.

## Contrats d’échange sur rendement total (TRS)		Pays des contreparties

## Règlement et compensation

## Emerging Markets Equity Fund	R.-U., É.-U.	Dérivés de gré à gré*

## MS Swiss Life Multi-Asset Protected Fund	R.-U., É.-U.	Dérivés de gré à gré*

## MSCI Emerging Markets ESG Equity Fund	R.-U., É.-U.	Dérivés de gré à gré*

## MS Scientific Beta US Equity Factors UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## 80% Protected Index Portfolio	R.-U., É.-U.	Dérivés de gré à gré*

## Cautious 85% Protected Fund	R.-U., É.-U.	Dérivés de gré à gré*

## Equity Risk Managed Fund	R.-U., É.-U.	Dérivés de gré à gré*

## Moderate 80% Protected Fund	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFE Europe Equity 6F EW UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFE EM Equity 6F EW UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFE US Equity 6F EW UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFE Japan Equity 6F EW UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFE Pacific ex-Jap Equity 6F EW UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## ACUMEN Capital Protection Portfolio	R.-U., É.-U.	Dérivés de gré à gré*

## ACUMEN Megatrends Protection Portfolio	R.-U., É.-U.	Dérivés de gré à gré*

## Movestic Avancera 75	R.-U., É.-U.	Dérivés de gré à gré*

## Movestic Avancera 85	R.-U., É.-U.	Dérivés de gré à gré*

## ACUMEN ESG Protection Portfolio	R.-U., É.-U.	Dérivés de gré à gré*

## Pergola 90	R.-U., É.-U.	Dérivés de gré à gré*

## SciBeta HFI US Equity 6F EW (USD) UCITS ETF	R.-U., É.-U.	Dérivés de gré à gré*

## Zebra Kante™ 80 Protect	R.-U., É.-U.	Dérivés de gré à gré*

## Morgan Stanley Alpha Tracker UCITS Fund	R.-U., É.-U.	Dérivés de gré à gré*

## Ibercaja Vida Consolida Sostenible	R.-U., É.-U.	Dérivés de gré à gré*

## *Les dérivés de gré à gré font l’objet de contrats bilatéraux.